Edwards Lifesciences Corporation Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)
Edwards Lifesciences Corporation (EW) reported Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) of $8.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Income Statement › Other Income
us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss · last filed 2026-02-25
- Edwards Lifesciences Corporation defined benefit plan, plan assets, foreign currency translation gain (loss) for fiscal 2025 was $8.00M.
- Edwards Lifesciences Corporation defined benefit plan, plan assets, foreign currency translation gain (loss) for fiscal 2024 was -$3.80M, a 252.00% decline from fiscal 2023.
- Edwards Lifesciences Corporation defined benefit plan, plan assets, foreign currency translation gain (loss) for fiscal 2023 was $2.50M.
| Period end | Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|
| 2025-12-31 | $8.00M 10-K · filed 2026-02-25 |
| 2024-12-31 | -$3.80M 10-K · filed 2026-02-25 |
| 2023-12-31 | $2.50M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |